Tiny implants take aim at prostate cancer: a smarter shot?
NCT ID NCT01902680
First seen Apr 18, 2026 · Last updated Jun 23, 2026 · Updated 7 times
Summary
This study tested a precise radiation implant (brachytherapy) for men with low-risk prostate cancer. Instead of treating the whole prostate, doctors placed radioactive seeds only in the tumor area. The goal was to see if this targeted approach could deliver the right radiation dose safely. Only 18 men took part, and the study is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Claudius REGAUD
Toulouse, 31059, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Iodine-125 (I125) radioactive implant
What this could lead to
If successful, this could show that a targeted radiation implant can control low-risk prostate cancer with fewer side effects than whole-gland treatment.
What could go wrong
This is a very small, early-phase study with only 18 participants. It focuses on technical feasibility, not long-term cancer control or cure. The approach may not work for all patients or may miss cancer cells outside the targeted area.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.